Document is current
Any future updates will be listed below
-
Authors
Melchers, Max
Pickkers, Peter
van Zanten, Arthur Raymond Hubert https://orcid.org/0000-0001-6276-7192
-
Funding
Funding for this research was provided by:
AOP Health
- License Information
-
More Information
Article History
Received: 8 June 2026
Accepted: 16 June 2026
First Online: 17 July 2026
Declarations
Ethics approval and consent to participate: The primary study received a waiver from the Dutch ‘Medical Research Involving Human Subjects Act’ from the medical ethical committee of Wageningen University and Research on December 20, 2020. Informed consent was obtained from each subject or, when applicable, from a legal representative, next of kin, or proxy in accordance to local protocols.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
Conflict of interests: MM reported receiving honoraria for advisory board meetings, lectures, and travel expenses from AOP pharma. PP reported receiving honoraria for advisory board meetings, lectures, research, and travel expenses from AOP Pharma, AM-Pharma, EBI, 4Teen4, and Adrenomed. AvZ reported receiving honoraria for advisory board meetings, lectures, research, and travel expenses from AOP Pharma, Abbott, Baxter, Cardinal Health, Danone-Nutricia, DIM3, Dutch Medical Food, Fresenius Kabi, GE Healthcare, InBody, Mermaid, Rousselot, and Lyric.
